Sulindac, 3,3’-diindolylmethane and curcumin reduce carcinogenesis in the Pirc rat, an Apc-driven model of colon carcinogenesis

BACKGROUND: Recently, we showed that Sulindac (SU; 320 ppm) reduces precancerous lesions in the colon of Pirc rats, mutated in the Apc gene. Surprisingly, previous data in Apc-mutated mice showed that SU, with reported efficacy in Familial Adenomatous Polyposis (FAP), increases colon carcinogenesis....

Descripción completa

Detalles Bibliográficos
Autores principales: Femia, Angelo Pietro, Soares, Paulo Victoria, Luceri, Cristina, Lodovici, Maura, Giannini, Augusto, Caderni, Giovanna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4559292/
https://www.ncbi.nlm.nih.gov/pubmed/26335331
http://dx.doi.org/10.1186/s12885-015-1627-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4559292/
https://www.ncbi.nlm.nih.gov/pubmed/26335331
http://dx.doi.org/10.1186/s12885-015-1627-9

Ejemplares similares